Approval of a novel antibody-drug conjugate ushers in new second-line option.

The vaccine has robust effects for multiple serotypes of pneumococcal disease.

Men were more likely than women to be prescribed dual blood-thinning therapy following a minor stroke or transient ischemic attack.

Single nasal swab test can determine whether a patient has COVID-19, influenza, respiratory syncytial virus, or a combination of these viruses in as little as 2 hours.

Academic and industry partnership to investigate new approach to treating lethal pancreatic cancer.

Early treatment of poor oral health could lead to brain health benefits.

Pimavanserin is an atypical antipsychotic indicated for the treatment of Parkinson disease-associated hallucinations and delusions.

These agents are likely to become the mainstay of cancer treatment in the very near future.

Patients with sepsis were 27% more likely to die, 38% more likely to be rehospitalized for any cause, and 43% more likely to return to the hospital specifically for cardiovascular causes.

Isatuximab and daratumumab offer promising treatment options for previously treated multiple myeloma.

Migraine could be considered a clinical marker of increased obstetric risk in pregnant women.

Bone marrow transplant could effectively change the brain’s blood vessels from abnormally narrowing.

Worse cases of periodontitis demonstrate association with progression of the scarring of the heart’s left atrium, data indicate.

Data show pharmacist-led clinical consultations can improve patient adherence to medication plans.

The economic burden of symptoms of major depressive disorder were estimated to cost $326 billion for the United States in 2018 alone.

Your pharmacy’s bottom line needs a smarter pricing system to keep up with a tech-smart customer. But when should you make the move?

The knowledge of clinical pharmacists can help protect kidney function and prevent the development of acute kidney injury in ICU patients.

The approval is for the youngest patient population with hereditary angioedema to date.

Patients with triple-negative breast cancer treated with veliparib had statistically significantly longer survival than those given placebo.

In a clinical trial program, 92% of health care providers, patients, and caregivers were able to successfully administer tezepelumab-ekko both in the clinic and at home for severe asthma.

Ultra-processed food consumption linked to an increased risk of developing and dying from ovarian cancer and breast cancer.

Belimumab was the first and only approved biologic for active systemic lupus erythematosus and lupus nephritis in more than 50 years, including for pediatric patients.

Participants also generally prefer newer injectable pre-exposure prophylaxis compared to pills for HIV prevention.

Study findings mark the first evidence of improved health-related quality of life scores following treatment with an investigational microbiome agent in patients with recurrent Clostridioides difficile.

The film traces the rise and fall of identical twin brothers Chris and Jeff George, who trafficked more than $500 million in opioid pills from their clinics.